Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
joincare.com

See what CB Insights has to offer

Investments

2

About Joincare Pharmaceutical Group

Joincare Pharmaceutical (SHA: 600380) is a comprehensive group company integrating R&D, production, sales and service of medicines and health products. The product range covers various fields such as chemical preparations, chemical raw materials and intermediates, diagnostic reagents, Chinese medicine preparations, and health care products.

Joincare Pharmaceutical Group Headquarter Location

Joincare Building 17 Langshan Rd, Nanshan District

Shenzhen, Guangdong,

China

+86 0755 86252388

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Joincare Pharmaceutical Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Joincare Pharmaceutical Group Rank

Latest Joincare Pharmaceutical Group News

Livzon Pharmaceutical Group Co Ltd 000513 Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $240

Nov 22, 2019

Printed From BioPortfolio.com Livzon Pharmaceutical Group Co Ltd 000513 Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $240 09:22 EST 22 Nov 2019 | BioPortfolio Reports Summary Livzon Pharmaceutical Group Co Ltd Livzon, a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and intermediates, and diagnostic reagents and equipment. Its products include menotropins injection, urofollitropin injection, perospirone hydrochloride tablets, and ranitidine bismuth citrate tablets, among others. Livzon offers diagnostic kits such as BV quicktest kit, antiHCV rapid test, antiHAV IgM ELISA kit, antiTOXO IgG ELISA and HBsAg ELISA kit. The company offers drugs for various therapeutic areas such as antibiotics, antibacterial, gastrointestinal, psychotropic, antiviral, immunomodulation, antiallergic and traditional Chinese medicine . It operates through its production facility located in Shanxi, Gansu and Yunan, China. Livzon is headquartered in Zhuhai, China. This comprehensive SWOT profile of Livzon Pharmaceutical Group Co Ltd provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Livzon Pharmaceutical Group Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends. The profile contains critical company information including*, Business description A detailed description of the company's operations and business divisions. Corporate strategy Analyst's summarization of the company's business strategy. SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats. Company history Progression of key events associated with the company. Major products and services A list of major products, services and brands of the company. Key competitors A list of key competitors to the company. Key employees A list of the key executives of the company. Executive biographies A brief summary of the executives' employment history. Key operational heads A list of personnel heading key departments/functions. Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history. Note*: Some sections may be missing if data is unavailable for the company. Key benefits of buying this profile include, You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Related Biotechnology, Pharmaceutical and Healthcare News

Joincare Pharmaceutical Group Investments

2 Investments

Joincare Pharmaceutical Group has made 2 investments. Their latest investment was in Feellife as part of their Seed on August 8, 2017.

CBI Logo

Joincare Pharmaceutical Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/8/2017

Seed

Feellife

Yes

1

1/27/2016

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/8/2017

1/27/2016

Round

Seed

Series C

Company

Feellife

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.